5% Drop Today In Bristol-Myers Squibb Stock – Mon Jun 4 2018
For the third time in a year and a half, disappointing clinical trials from Bristol-Myers Squibb...
Read MoreFor the third time in a year and a half, disappointing clinical trials from Bristol-Myers Squibb...
Read MoreFor the second time in a year and a half, clinical trials of the Opdivo drug failed to impress and...
Read MoreDisappointing news on Bristol-Myers Squibb’s immunotherapy combo medication has the stock...
Read MoreOne stock that has been in my portfolio for years in Bristol-Myers Squibb Stock. The decline today...
Read MoreIt was just back on September 27 I was writing about the repairs I had entered on my trades in...
Read More